Evident Vascular

Executive Summary

Evident Vascular is a private medical device company developing an advanced intravascular ultrasound (IVUS) platform enhanced by artificial intelligence (AI) to improve image interpretation and clinical workflows in peripheral vascular interventions. Founded in 2017 and headquartered in Irvine, CA, the company aims to disrupt the IVUS market by addressing the limitations of legacy systems originally designed for coronary procedures, which are suboptimal for peripheral applications. Its AI-driven technology promises superior image quality and real-time assistance, potentially reducing procedure times and improving patient outcomes. By focusing exclusively on the peripheral vascular space, Evident Vascular differentiates itself from competitors and targets a significant unmet need in the growing peripheral intervention market. The peripheral IVUS market is poised for expansion as operators increasingly recognize the value of imaging guidance for complex lesions, and Evident's solution could capture meaningful share by providing a purpose-built platform with integrated AI. While the company remains in a relatively early stage, its innovative approach and clear clinical rationale position it well for future growth, pending successful regulatory clearances and clinical validation. We assign a conviction score of 70, reflecting moderate confidence in the technology's potential balanced against the uncertainties of a pre-commercial medical device company.

Upcoming Catalysts (preview)

• Q2 2027FDA 510(k) clearance for next-generation IVUS system75% success
• Q4 2026Initiation of pivotal clinical trial for AI-enabled IVUS65% success
• TBDStrategic partnership or distribution agreement with major cardiovascular device company50% success